Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus D...
Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract Purpose The EINSTEIN-Extension trial showed that an extended rivaroxaban treatment significantly reduced the risk for venous thromboembolic (VTE) recurrence. The present study assessed the risk for VTE recurrence and major bleeding associated with extended rivaroxaban treatment in a clinical practice setting among patients with VTE. Method...
Alternative Titles
Full title
Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-Treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1913396819
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1913396819
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2017.05.357
